YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis.

You Q, Yao Y, Wu J, Cheng C, Li Y, Yuan H

Open source

DOI
10.1016/j.biopha.2020.110339
Published
2020 Sep
Container
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2020.110339,
  title = {YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis.},
  author = {You Q and Yao Y and Wu J and Cheng C and Li Y and Yuan H},
  year = {2020},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2020.110339},
  url = {https://doi.org/10.1016/j.biopha.2020.110339}
}

RIS

TY  - JOUR
TI  - YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis.
AU  - You Q
AU  - Yao Y
AU  - Wu J
AU  - Cheng C
AU  - Li Y
AU  - Yuan H
PY  - 2020
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2020.110339
UR  - https://doi.org/10.1016/j.biopha.2020.110339
ER  - 

APA

Q, Y., Y, Y., J, W., C, C., Y, L., & H, Y. (2020). YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2020.110339

Source records